Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells. - Wikidata - wikimedia - TriplyDB

Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells.

Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells.

http://www.wikidata.org/entity/Q37618532

about

Gene therapy for hemophilia The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity Recent advances in lentiviral vector development and applications.New approaches to gene and cell therapy for hemophilia.Therapeutic potential of hematopoietic cells derived from pluripotent stem cells.Platelet-directed gene therapy overcomes inhibitory antibodies to factor VIII.Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.

P2860

Q28081911-E3D8C26B-6C7D-4C2A-9459-2290FA2EAB5C Q36054608-DEDA7D15-6EDA-4E68-951E-5E76D1CB3F83 Q37678176-FE6F16F2-7935-4695-8B97-F3E67569B0A4 Q38543280-8F9B57E5-10E5-48C4-93C5-A225FB7B760C Q44431905-BC1334F2-BACA-49E6-919C-2A0D0DF0DD98 Q45879389-89CFED65-2AB6-4C52-99CD-2F4919AEFB37 Q45885814-646DE261-B08A-48EF-BED1-A3D426A66036

P2860

Supplying clotting factors from hematopoietic stem cell-derived erythroid and megakaryocytic lineage cells.

http://www.wikidata.org/entity/Q37618532

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@en

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@nl

type

label

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@en

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@nl

prefLabel

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@en

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@nl

P1433

Q37618532-7ED415F7-2A37-41AD-872A-F93B6F6FE881

P1476

Q37618532-F6618A17-3B3B-4A00-AD66-2EE8D4D625D1

P2093

Q37618532-B85FE236-75C7-4830-8247-F9FA6127836E

Q37618532-C8DE67DD-1818-4C14-A92B-027D59142AE0

Q37618532-EBD001EA-4021-491D-9CA5-92588454ECE9

P2860

Q37618532-096A5C2A-1580-47D1-B567-5E9C7C8375EA

Q37618532-0FDF500D-1D9F-4D4B-BD02-E18F6313B33F

Q37618532-10063589-7BB2-4586-AF70-EF752E182E17

Q37618532-1E1A5129-8F42-4E10-951F-D24F88A6F3BC

Q37618532-21273C37-E96F-45E5-AD24-0A5E56BB2EEF

Q37618532-228C9AA6-D9AE-488C-BA9F-CDE378EF6106

Q37618532-346F4623-615F-4156-881D-C60A693E095F

Q37618532-358BCC6D-5B0D-4D63-9924-07B6D0487DD8

Q37618532-36DB06B0-BF65-476C-A55A-9E12E7D986F0

Q37618532-3CFFE0C6-4525-46D7-8F42-DFF3FEDB65E0

P304

Q37618532-8E7A0B56-4929-46DD-B57B-0A5EA4C1AA61

P31

Q37618532-1C4A3906-7151-4333-8A00-9800ECB4950C

P356

Q37618532-A4949E62-FC9A-4C64-9D71-DF5D5E40BFCC

P433

Q37618532-931B68F4-2A46-4CEE-928F-E96C4BC0C334

P478

Q37618532-234D4D62-5E6B-4F01-B287-9741C30307D4

P577

Q37618532-13C75572-C7BC-465A-AC23-F62BA69EF0EB

P5875

Q37618532-57EFA678-68AC-4E71-919F-F7071DBE2255

P698

Q37618532-93F5F306-E159-401E-A60C-F3808FC7A0C5

P932

Q37618532-746C14A2-7ABE-4428-AC01-189FE85A4B1F

P356

P1433

Molecular Therapy

P1476

Supplying clotting factors fro ...... megakaryocytic lineage cells.

@en

P2093

Alex Chang

http://www.w3.org/2001/XMLSchema#string

Leszek Lisowski

http://www.w3.org/2001/XMLSchema#string

Michel Sadelain

http://www.w3.org/2001/XMLSchema#string

P2860

Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors.

Gene specificity of suppression of transgene-mediated insertional transcriptional activation by the chicken HS4 insulator.

Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator.

Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.

Side effects of retroviral gene transfer into hematopoietic stem cells.

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.

P304

1994-1999

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.238

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38025161

http://www.w3.org/2001/XMLSchema#string

P698

19844194

http://www.w3.org/2001/XMLSchema#string

P932

2814379

http://www.w3.org/2001/XMLSchema#string